Heart Valve Disease – Aortic and Mitral

  • sponsor
Updated on 5 February 2021
aortic valve replacement


Study Description:

Multi-center, international, prospective, randomized, interventional, pre-market study. Patients will be seen at pre and post-procedure, discharge, 30 days, 6 months, 1 year, 18 months, and annually through 10 years.
Randomly assigned (50% to either group) Treatment of Aortic Stenosis with either Transcatheter Aortic Valve Replacement (TAVR) device or Treatment of Aortic Stenosis with commercial Surgical Aortic Valve Replacement (SAVR).


Eligibility Criteria:

Once you have decided to participate and have learned of the details of the trial you will be seen and evaluated for the following:
To be eligible to participate you will be evaluated for Severity of aortic stenosis. You must meet criteria for heart team agreement of low risk for Surgical Aortic Valve Replacement, where low risk is defined as predicted risk of mortality < 3% at 30 days.
Other criteria are required to be met based on measurements obtained from echocardiograms and computed tomography images.
Exclusions include specific anatomic characteristics of your diseased valve such as a bicuspid valve, additional surgical access exclusions and any condition considered a contraindication for placement of a bioprosthetic valve.

Other Details:

Participating in a study is a personal decision. You may wish to talk with family members or friends and your doctor before deciding to join a study. You or your doctor may contact the study research staff through the contacts provided on this page. Patients interested in participation in the trial are referred to our practice through a referring cardiologist.

Condition Aortic Stenosis, Atrial Fibrillation, Atrial Fibrillation, Atrial Fibrillation (Pediatric), VALVULAR HEART DISEASE, Heart Valve Disease, Atrial Fibrillation (Pediatric), Heart Valve Disease
Clinical Study IdentifierTX133772
Last Modified on5 February 2021


How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note